Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Increase in Online Prescriptions During COVID-19 Pandemic

Key Points: Traditional pharmacy services make getting prescriptions complicated. Pharmacies turned to online models during the pandemic. Pharmaserve allows customers to get their prescriptions filled online. Commentary: Getting your prescription medication can be a pain, especially when it requires you to go into a pharmacy to go and get it. But more options are…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Increase in Online Prescriptions During COVID-19 Pandemic

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Key Points:

  • Traditional pharmacy services make getting prescriptions complicated.
  • Pharmacies turned to online models during the pandemic.
  • Pharmaserve allows customers to get their prescriptions filled online.

Commentary:

Getting your prescription medication can be a pain, especially when it requires you to go into a pharmacy to go and get it. But more options are starting to appear like Pharmaserve, a Canadian-based online pharmaceutical platform that allows consumers to get their prescriptions refilled online rather than having to stand in line at your local pharmacy. We asked Seun Bammeke, Managing Director of Pharmaserve, how they have been able to manage the pain in the process of buying prescription pills online. Like everything in the past year and a half, online versions of anything have become more popular. We also asked Bammeke how the hyper-focus of making everything socially distant or contact-free helped speed up users’ adoption of their services.

Abridged Thoughts:

We sell and ship prescription medication to the United States, so there are typically often many pain points. However, we’ve been able to eliminate a lot of them for our customers. So, for example, since we do not have a physical location, our costs are substantially less than your typical brick and mortar brick and mortar pharmacy apologies. And so, because of that, we are able to pass on a lot of the savings directly onto our customers, which means they’re even cheaper medications for that.

Well, fortunately, the pharmacy has always been fully online. However, our customers’ adoption rate has increased dramatically due to the current world pandemic. We have proven to our patients and prospective patients, they’re able that we are able to provide them with a safe way of delivering their medications while ensuring that it is affordable to our patients. Companies throughout this pandemic have found ways to step up and fill in a void where it is needed and, in turn, made some even more successful or well known.

With Merck’s COVID Antiviral Announcement, Can the Pharma Pipeline Build Treatment Momentum?

What is Behind the “Mergers & Acquisitions” Boom in Healthcare?

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage. Holland & Knight said hospitals will be eligible for NTAP reimbursement for use of Aidoc’s CARE Body CT Multi-Triage beginning Oct. 1, 2026, with supplemental payments continuing for three years.

  • 01Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage.
  • 02Holland & Knight said CMS approved an NTAP designation for Aidoc’s CARE Body CT Multi-Triage, with hospitals eligible for NTAP reimbursement beginning Oct. 1, 2026, with supplemental payments continuing for three years.

Sep 23, 2026

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raised CAD $4.24 million in a pre-seed round, according to Fierce Healthcare. It plans to expand protocol-driven virtual specialty care across Canada and the U.S.

  • 01Blair Health raised CAD $4.24 million in pre-seed funding.
  • 02Qualified Health positions its AI platform around safety and governance, including clinician oversight, auditability and traceability, according to Fierce Healthcare.

Sep 23, 2026

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512